Back to search

Boston University

Tuberculosis increases the survival of B-cells through the BAFF system molecules in HIV patients

Abstract

dc:description.abstract

Since the human immunodeficiency virus (HIV) epidemic in the 1980s, great strides have been made regarding drug therapeutics, which has slowed the progression of HIV to AIDS and decreased the mortality rates in HIV patient populations. Other prevention interventions, such as pre-exposure prophylaxis (PrEP), have also contributed immensely to reducing HIV infections. However, today in many parts of the world, especially in sub-Saharan Africa, HIV is still prevalent. This demonstrates the need to focus on more long-term preventative interventions, such as vaccines. In order to do this, more research has to be conducted on the B cell adaptive immune response to HIV. This thesis research explores how the opportunistic disease tuberculosis, which is present in many HIV-positive patients, affects B cell survival in these HIV patients. Our methods section consists of CD14+ cell isolation and MDM culture experiments that we performed and subsequent planned experiments that we are yet to complete. These experiments include infecting MDM cultures with a double pseudotyped VSVg-NL43 HIV. We will also expose the MDMs to the TB antigen, lipomannan (LM), to represent HIV/TB co-infection in vitro. LM is a toll-like receptor 2 (TLR2) agonist. The MDM cultures will enable us to measure the amount of BAFF and APRIL mRNA produced in the HIV, HIV/LM, and LM MDM cultures using RT-PCR. Using a growth curve, we will observe BAFF and APRIL's effects on the survival of B cells in the different MDM cultures. We hypothesize that the TB antigen will increase B-cell survival through the BAFF system molecules in HIV patients. The results of our research will provide insights on the role TB plays in enhancing the humoral immune response in HIV-1 patients, paving the way for further research on understanding the mechanism responsible for this and consequently creating vaccine and vaccine adjuvant opportunities.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Asante, Phoebe Ohemah
Advisors dc:contributor.advisor
  • Sagar, Manish
  • Franzblau, Carl

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/43323

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Asante, Phoebe Ohemah. Tuberculosis increases the survival of B-cells through the BAFF system molecules in HIV patients. masters thesis, Boston University, 2021. https://hdl.handle.net/2144/43323